<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03300648</url>
  </required_header>
  <id_info>
    <org_study_id>TBS</org_study_id>
    <secondary_id>U01AI126610</secondary_id>
    <nct_id>NCT03300648</nct_id>
  </id_info>
  <brief_title>Treating Brain Swelling in Pediatric Cerebral Malaria</brief_title>
  <acronym>TBS</acronym>
  <official_title>Treating Brain Swelling in Pediatric Cerebral Malaria</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Michigan State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Maryland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Michigan State University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the effectiveness of two interventions in Malawian children with
      cerebral malaria at high risk of death. One-third of the participants will receive treatment
      as usual, one-third will receive treatment as usual and be placed on a mechanical ventilator,
      and one-third will receive treatment as usual plus intravenous hypertonic saline.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      An important mechanism of death in children with cerebral malaria is diffuse cerebral
      swelling, cerebral herniation, compression of the brainstem respiratory center, and
      respiratory arrest. In those who survive their illness without specific interventions,
      reversal of diffuse cerebral swelling is rapid.

      Mechanical ventilation may help to preserve life while diffuse brain swelling diminishes.
      Intravenous hypertonic saline may work as an osmotic diuretic, directly decreasing brain
      swelling.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 8, 2018</start_date>
  <completion_date type="Anticipated">November 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2023</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants will be randomly assigned to one of three study arms.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Investigators assessing outcome will be blinded to the arm to which the participant was randomly assigned</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>Within 7 days of randomization</time_frame>
    <description>Alive or dead</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neurodevelopmental disability</measure>
    <time_frame>1 year</time_frame>
    <description>Presence and severity of neurodevelopmental disability in survivors</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">261</enrollment>
  <condition>Malaria, Cerebral</condition>
  <arm_group>
    <arm_group_label>Unual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Hospitalization in a high dependency pediatric unit with skilled nursing, intravenous artesunate followed by oral artemisinin combination therapy, intravenous fluids, nasogastric feeding, elevation of the head of the bed by 30 degrees</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mechanical ventilation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hospitalization in a high dependency pediatric unit with skilled nursing, intravenous artesunate followed by oral artemisinin combination therapy, intravenous fluids, nasogastric feeding, elevation of the head of the bed by 30 degrees, along with intubation and mechanical ventilation for a maximum of 7 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hypertonic saline</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hospitalization in a high dependency pediatric unit with skilled nursing, intravenous artesunate followed by oral artemisinin combination therapy, intravenous fluids, nasogastric feeding, elevation of the head of the bed by 30 degrees, along with intravenous 3% hypertonic saline for a maximum of 7 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Mechanical ventilation</intervention_name>
    <description>Intubation and mechanical ventilation for a maximum of 7 days</description>
    <arm_group_label>Mechanical ventilation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hypertonic saline</intervention_name>
    <description>Intravenous 3 percent hypertonic saline for a maximum of 7 days</description>
    <arm_group_label>Hypertonic saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Peripheral P. falciparum parasitemia of any density

          -  Blantyre Coma Score â‰¤2

          -  No evidence of meningitis on lumbar puncture

          -  Consciousness not regained after correction of hypoglycemia (if hypoglycemia is
             present)

          -  Male or female whose age on the day of screening is between 6 months and 12 years old

          -  Severely increased brain volume on magnetic resonance imaging

          -  Provision of consent by guardian

          -  Willingness to return for 1, 3, 6, and 12 month post-randomization follow-up visits

        Exclusion Criteria:

          -  Gross malnutrition as evidenced by peripheral edema, hair color changes, or severe
             wasting

          -  Advanced Human Immunodeficiency Virus (HIV) disease - defined as known HIV positive
             status and evidence of severe wasting

          -  Evidence of recent head trauma by history or physical examination

          -  Pneumonia as evidenced by oxygen saturation on room air of &lt;85%

          -  Gastroenteritis and shock as evidenced by capillary refill &gt;3 seconds or skin tenting
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Terrie E Taylor, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Michigan State University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Terrie E Taylor, DO</last_name>
    <phone>231-883-5948</phone>
    <email>ttmalawi@msu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Douglas G Postels, MD</last_name>
    <phone>505-256-4929</phone>
    <email>dpostels@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Queen Elizabeth Central Hospital</name>
      <address>
        <city>Blantyre</city>
        <country>Malawi</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Terrie E Taylor, DO</last_name>
      <phone>+265 999 96 92 20</phone>
      <email>ttmalawi@msu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Douglas G Postels, MD</last_name>
      <phone>505-256-4929</phone>
      <email>dpostels@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Malawi</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 28, 2017</study_first_submitted>
  <study_first_submitted_qc>September 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 3, 2017</study_first_posted>
  <last_update_submitted>September 28, 2017</last_update_submitted>
  <last_update_submitted_qc>September 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Michigan State University</investigator_affiliation>
    <investigator_full_name>Terrie Taylor</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>coma</keyword>
  <keyword>pediatrics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malaria</mesh_term>
    <mesh_term>Malaria, Cerebral</mesh_term>
    <mesh_term>Brain Edema</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Deidentified individual participant data may be made available to other researchers</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

